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Intrapartum Fetal Heart Rate 
Monitoring:
Using audit methodology to identify areas for research and practice improvement
abstract
The purpose of the study was to explore the fetal heart 
rate monitoring practices of midwives and doctors 
to determine compliance with an evidence-based 
guideline for fetal heart rate monitoring endorsed 
by one New Zealand (NZ) District Health Board 
(DHB).  A retrospective audit of 193 randomly 
selected medical records was undertaken over six 
months (July-December 2006). The audit revealed 
deficiencies in choice of fetal heart rate monitoring 
modality, monitoring technique, documentation, 
communication and use of a standardised approach 
and language for interpreting cardiotocograph (CTG) 
traces especially the description and categorisation of 
the four main fetal heart rate features. Multidisciplinary 
education and a standardised template for reporting 
CTG’s were key recommendations.
Keywords:
Intrapartum Care, Fetal Monitoring, Midwifery, 
Clinical Effectiveness, Audit; 
introduction
The assessment of fetal well-being during labour is 
one component of a total package of intrapartum care 
provided to women. Intrapartum fetal surveillance 
aims to improve fetal outcomes by identifying fetuses 
with hypoxic acidaemia and has the potential to 
promote fetal health and improve neonatal status at 
birth. However, electronic fetal monitoring (EFM) 
as a stand-alone tool is ineffective in avoiding 
preventable adverse outcomes (Alfirevic, Devane 
& Gyte (2006). It is effective only when used in 
accordance with published standards and guidelines 
and when appropriate timely intervention is based 
on that interpretation (Simpson & Knox, 2000). 
Since the introduction of EFM over three decades 
ago women’s intrapartum care has been increasingly 
dominated by the use of technology but there 
continue to be concerns around the interpretation of 
the findings of EFM and the effects on women and 
babies. Over time experts have agreed on guidelines 
for intrapartum fetal monitoring practice based on the 
best available evidence and professional organisations 
have developed templates to assist practitioners to 
accurately interpret the findings of EFM and the 
appropriate action to take based on the interpretation. 
Case reviews following unexpected obstetric 
outcome have identified (amongst other things) 
substandard practice in relation to fetal heart rate 
(FHR) monitoring during labour (Miller, 2005). 
Such practices have included not using the most 
appropriate method of FHR monitoring, poor 
quality FHR monitoring; failure to use a structured 
approach to assessing the four main features 
of FHR monitoring (baseline rate, variability, 
accelerations, and decelerations), failure to interpret 
the FHR monitoring in a timely manner that 
enables a diagnosis of fetal distress and appropriate 
interventions and failure to use a chain of command 
to resolve clinical disagreements (ibid). It must also 
be highlighted that to assess these four main features 
of FHR monitoring appropriately there needs 
to be concurrent monitoring of uterine activity. 
Interpretation and management of FHR monitoring 
in labour continues to be a common issue in litigation 
(in countries where this is possible) involving 
adverse outcomes in term pregnancies (ibid). The 
United Kingdom (UK) Confidential Enquiry into 
Stillbirths and Deaths in Infancy (CESDI, 2001) 
has highlighted that errors in interpretations of 
FHR monitoring are a major contributor to infant 
morbidity and mortality. Globally it is known that 
inter-observer and intra-observer consistency is poor 
when it comes to interpretation of the findings of 
FHR monitoring (Simpson & Knox, 2000). 
This paper describes the findings of a retrospective 
audit of one DHB’s compliance with its current 
evidence-based policy for intrapartum fetal heart rate 
monitoring. Audit is a quality assurance process in 
health care that supports practitioners to constantly 
seek to improve care. Audit is defined as ‘deciding 
what should be, comparing what should be with 
reality, identifying the gaps and taking action’ (Morrell 
& Harvey, 1999, p.1). The developing profile of 
evidence-based medicine and clinical effectiveness 
emphasises the importance of the role of clinical audit 
when it comes to getting research into practice (ibid). 
background to thE study
A small number of cases of unexplained perinatal 
asphyxia in babies requiring admission to the neonatal 
intensive care unit triggered senior staff of the DHB to 
investigate possible causes. Questions were asked about 
fetal surveillance in labour. The delivery unit in which 
these babies were born has an evidence-based policy 
for intrapartum EFM, which includes guidelines for 
intermittent auscultation (IA) and fetal blood sampling 
(FBS), based on the Royal College of Obstetricians and 
Gynaecologists (RCOG) / National Institute of Clinical 
Excellence (NICE) guidelines (RCOG, 2001). 
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A preliminary review of several maternal medical 
records suggested there were deficiencies around 
compliance with the policy including decision-
making around fetal monitoring modality, 
interpretation and classification of the four main 
features of FHR monitoring, use of concurrent 
uterine activity monitoring, documentation and 
action plans. As a result of this, a group of senior 
midwives from the DHB were enrolled to conduct 
a study of intrapartum fetal heart rate monitoring 
practices of midwives and doctors over a period of six 
months at the end of 2006. An audit methodology 
was chosen to determine the current state of practice 
in relation to the DHB intrapartum fetal heart rate 
monitoring policy, to discover where the major gaps 
were in practice and inform the design of an ongoing 
multidisciplinary education programme.
The setting for the study included the three maternity 
facilities (primary, secondary and tertiary), managed 
by one DHB in a major city in NZ. The level three 
tertiary referral unit, with a Maternal Fetal Medicine 
unit, caters for over 3000 births per year and 
incorporates  level O primary maternity facilities in 
the suburbs 30-60 minutes from the unit. Women 
receive primary maternity care from a named lead 
maternity carer (LMC) either in the community or 
through the hospital. Choices of birthing facilities 
include the secondary/tertiary delivery suite or the 
primary maternity units. A multidisciplinary team, 
including core midwifery services, provide care for 
women receiving secondary or tertiary care. 
mEthods     
Policy selection
The policy against which current practice was 
measured is, “The Intrapartum Electronic Fetal 
Monitoring (EFM) and Fetal Blood Sampling (FBS) 
Policy”, issued by the DHB in October 2003 and 
reviewed in October 2005. The policy, largely based 
on the RCOG evidenced-based clinical guideline 
Number 8 (2001), was developed by the Clinical 
Leader – Obstetrics, two midwifery policy and quality 
facilitators and authorised by the Women’s Health 
Service medical Clinical Director.                 
Medical record selection
193 sets of medical records from women who gave 
birth within the DHB’s three campuses, which 
included primary, secondary and tertiary level care, 
were audited over a six month period. 
Sample size
The number of medical records needing to be audited 
to have 95% confidence (+/- 5% accuracy) from the 
whole population was estimated to be 340 based on 
the DHB’s 2005 birth figures (http://www.ubht.org.
uk/clinicalaudit/ClinicalAudit/). In most audits a small 
snapshot sample will probably be sufficient to indicate 
where standards are not being met. The pragmatic 
guideline for selecting the audit size is to enrol enough 
‘patients’ so that senior clinicians/managers will be willing 
to implement changes based on the findings. Due to 
circumstances outside the control of the audit team (staff 
shortages, increased workload) it became difficult to 
audit as many notes as was planned and a compromise 
was made to select a more pragmatic sample size. The 
audit was suspended temporarily after a month to check 
consistency of data entry and to introduce samples from 
the DHB’s two Primary Maternity Units.  Before the 
audit ended in December 2006, a trend was establishing 
and it was apparent from early analysis that continuing 
to collect data would be unlikely to add any further new 
information to the findings. 
Randomisation and chart selection
Using the Patient Information Management System 
(PIMS) and an Excel randomisation function, 25 
medical records were randomly selected per week 
from a dataset of women who met the inclusion 
criteria (DHB birth, and not an elective caesarean 
section (CS). The selected medical records were 
identified by their unique identifying National 
Health Index (NHI) numbers. 
Data collection
An audit tool was designed using an Excel spreadsheet 
with criteria that reflected the content of the policy. 
Data were entered by the auditors onto an Excel 
spreadsheet as they completed each set of case notes. 
Data were analysed at the end of each month and 
summarised at the end of the six months.
 Validity and reliability
The auditors met to discuss interpretation of the 
criteria to ensure these were understandable and 
unambiguous.  Changes to the wording of some 
criteria were made and definitions were checked 
against the policy. To test for inter-rater reliability, 
a trial run of the data collection tool against 10 
sets of medical records took place with all auditors 
together in one room. This enabled them to cross 
check interpretations against the policy and with 
fellow auditors. Definitions were validated and minor 
modifications were made to the audit tool. This 
ensured consistency and stability of the audit tool.
Ethical considerations
The audit was conducted within an ethical framework 
which included, maintaining patient and staff 
confidentiality, anonymising information contained 
in the project final report, not collecting unnecessary 
data, destruction of data collection forms once they 
had served their purpose for the audit. The proposal 
was approved by the DHB Women’s Health Service 
(WHS) clinical audit committee, business manager 
and medical clinical director.
Data analysis
Simple descriptive statistics (frequencies/percentages), 
dichotomous measures (Yes/No) and outcome measures 
using the categories of ‘Always/Sometimes/Never’  were 
used for data analysis. These measurements applied to 
situations where an assessment and the recording of it 
were required more than once. 
findings 
For the analysis, ‘caregiver at the time of booking’ was 
used.  Caregiver categories described in the DHB 
annual clinical reports i.e self-employed midwife 
LMC, medical LMC with self-employed midwife 
(shared care), medical LMC with hospital midwife 
(shared care), hospital primary team (hospital 
midwifery LMC) and hospital high risk team care 
were used.  Of the 193 medical records analysed the 
spread of caregivers was representative of the 2006 
DHB figures as revealed in Table 1. Medical records 
from across the DHB’s three campuses were included 
in the audit and were representative of the percentage 
of births across these three settings and levels of care. 
Choice of monitoring: Electronic fetal monitoring 
included admission CTG, intermittent EFM and 
continuous EFM (CEFM) The data collection around 
EFM was not mutually exclusive. Some women had 
an admission CTG and continued on with CEFM, 
others had intermittent auscultation (IA) and moved 
onto CEFM. Measured against the indications for 
EFM from the policy, 37.3% of women in this audit 
had no indications for EFM. Of women without 
indications for EFM 54.1% received IA. Induction or 
augmentation of labour and epidural were the most 
common indicators for use of EFM (Table 2). 
Admission CTG: Nearly 45% of women in the audit 
had an admission CTG regardless of antenatal ‘risk’ 
status. Seventy-one percent of the women who had 
an admission CTG had indications for intrapartum 
EFM according to the policy and 57% of these 
women went on to have CEFM. Of the women 
considered ‘low risk’, 37.5% had an admission CTG. 
Intermittent Auscultation (IA): Of the women eligible 
for IA (no risk factors for EFM) 54.1% had IA of the 
fetal heart rate during labour. Analysis of IA method 
was based on the documentation of frequency, timing 
and duration as outlined in the policy using the 
descriptors “Always”, “Sometimes” or “Never”.
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In relation to frequency of IA (every 15 to 30 
minutes) documentation revealed this was 
achieved  “Always” 71% of the time in first 
stage, 38% of the time in second stage, but only 
10% of the time in relation to duration (for one 
minute) and 23% for timing (after a contraction). 
Recording of the maternal pulse rate in first and 
second stage failed to reach optimal frequency as 
outlined in the policy (Table 3). 
Of the women with no risk factors for EFM and who 
were monitored using IA, 79% had normal vaginal 
births, 4% had assisted births, and 2.7% had an 
emergency CS (no outcome data were provided on 
the audit sheets for 10 women). A majority of babies 
had Apgar scores of nine or 10 at one minute.
Documentation standards for use and management 
of fetal monitoring equipment: There were 95 
episodes of CEFM. Analysis was based around the 
frequency of compliance with the standards for use 
and management of fetal monitoring equipment 
and CTGs i.e. correct use of the equipment, 
identification of the woman, date and time of the 
episode of monitoring and secure storage of CTGs. 
The responses were Yes/No expressed as percentages 
(Table 3). Approximately 30% of all CTG traces in 
this audit had incorrect date and time settings, 20% 
did not use the tocograph (to record contractions). 
The name of the woman undergoing monitoring 
was absent on 18% of CTG traces  and 28.5% of 
CTGs had no NHI number (unique identifier) 
on them either. From a medico-legal aspect it was 
interesting to note 11.6% of CTGs were not held 
securely in the medical record (Table 3).
Documentation standards for CTGs
This analysis relates to a standardised approach for 
documentation on CTG traces in relation to events 
(e.g. vaginal examination, epidural top-up) that 
may affect the fetal heart. Annotation of maternal 
observations and opinions expressed by colleagues 
who were asked for comments on traces are required 
to enable a consistent approach to interpretation of 
CTGs.  In each instance, compliance was less than 
optimal (Table 4).
Documentation of findings on CTG
The policy outlines two methods for the interpretation 
of the CTG. One method, the mnemonic, “DR C 
BRAVADO” from the Advanced Life Support in 
Obstetrics (ALSO) course (AAFP, 2001) provides 
a systematic approach to the assessment of CTGs. 
However, in this audit documentation revealed the 
mnemonic was only used in 12.6% instances of 
assessment. The alternative is to use an interpretation 
framework where all four fetal heart features (baseline 
rate, variability, accelerations and decelerations) are 
data 
source
Place of birth caregiver at booking
level 
2/3 unit
level o 
unit
level o 
unit         
lmc 
mwª      
dr & sE 
mwª
dr & 
hosp. 
mwª
hosp. 
Primary 
teamª
hosp. 
sec/
tert 
teamª
193 
Audited 
casenotes
168 
87%
14 
7.3%
11 
5.7%
135 
69.9%
17 
8.8%
22 
11.4%
13 
6.7%
6 
3.1%
DHB  
2006*
90.5% 6.4% 3.3% 66.3% 6.8% 12.8% 6.4% 7.7%
Table 1: Distribution of Place of Birth and Caregiver at Booking. 
ª code: lmc=lead maternity carer, mw=midwife, sE mw=self-employed midwife,  
sec/tert = secondary/tertiary
*data source: fisher, hawley, hardwick and Plunkett, 2006.
an maternal = 22 Elevated BP 8
PET 2
Diabetes 2
APH 0
Other 10
an fetal = 27 IUGR 3
Premature labour 3
Oligohydramnios 4
Abnormal Doppler 1
Abnormal CTG 1
Rh disease 1
Fetal anomaly 0
Twins 3
Breech 0
42 wks + gestation 1
Other -  Large for dates, PROM, Non-reassuring CTG x 2, 
not stated x 6 
10
intrapartum – labour = 78 Previous CS 13
SRM >24hrs 9
Induction of labour 22
Augmentation of labour 24
Hyper stimulation 2
1st stage > 12hrs 0
2nd stage > 2hrs 1
Other -  Augmented labour, Started IA then moved to 
CEFM, IOL became El CS, not stated x 4   
7
intrapartum – maternal 
= 23
Vaginal bleeding 0
Sepsis 1
Epidural 21
Temperature > 38 degrees 0
Other -  Mitral valve prolapse, not stated x 1 2
intrapartum – fetal = 18 Meconium liquor 6
Blood in liquour 0
Suspicious CTG 9
Other -  Variable decelerations quick labour, not stated x 2 3
Table 2: Indications for intrapartum EFM
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assessed and a standardised language to categorise the 
findings (reassuring, non-reassuring and abnormal) 
is employed to ensure consistency of understanding. 
The collective fetal heart rate findings are then 
described as normal, suspicious, or pathological. Use 
of these interpretation and classification guidelines in 
the documentation were assessed using the descriptors 
“Always”, “Sometimes” or “Never”.
Documentation of the baseline fetal heart rate 
was noted as achieved “Always” 40% of the 
time, 25% of the time for variability, 15% of the 
time for accelerations, and 20% of the time for 
decelerations (Table 4). As demonstrated in Table 
4, evidence of categorisation and description of the 
findings was less than optimal.
discussion
In this audit 37.3% of women had no indications 
for electronic fetal heart rate monitoring and were 
eligible for IA. However, only 54% of these women 
were actually monitored by IA. The remainder 
had some form of EFM. The birth environment 
has a part to play in the selection of fetal heart rate 
monitoring modality. Despite the fact that research 
and professional body guidelines for fetal heart rate 
monitoring recommend IA as the most appropriate 
method of fetal heart rate monitoring for women who 
are well and have had uncomplicated pregnancies 
(NICE, 2001; Liston et al, 2007; RANZCOG, 2006; 
MIDIRS, 2003, RCM, 2005; NZCOM, 2002: 
ACNM, 2007), it is apparent that the presence of 
technology within the hospital birth setting and the 
spoken or unspoken pressure from medical colleagues 
for the use EFM for all women influences midwive's 
practice and choices in monitoring modality. It 
is also acknowledged that intrapartum fetal heart 
rate monitoring often features in the reports from 
complaint and disciplinary bodies, which must have 
an impact on the choices made for intrapartum fetal 
heart rate monitoring. It would seem that in 2009 the 
quote from Boylan (1987) still holds true:
…it must also be emphasized that the method of 
fetal monitoring chosen may be strongly influenced 
by factors other than scientific evidence… where the 
medico legal climate is such that failure to rigorously 
document absence of fetal distress/true birth 
asphyxia may result in a harrowing lawsuit (p 73).
There needs to be ongoing discussion and 
education to support the practitioner’s initial 
assessment of risk factors in early labour to support 
decision-making about the most appropriate choice 
of monitoring modality.
Admission CTG
Nearly half of the women in this audit had an 
admission CTG. Thirty seven percent of the women 
Table 3: Documentation standards for CTG’s.
* nhi – national health index no. (unique identifier)
yes right 
date 
on 
paper
right 
time 
on 
paper
right 
speed 
1cm/
min
toco 
used
woman’s 
name
woman’s 
nhi*
date 
noted
time 
noted
secured 
in notes
% 69.4 72.6 87.3 80 82.1 71.5 66.3 58.9 88.4
documentation  
of ia  low risk 
women (n= 39  )
always sometimes never no 
data
total total 
%
no. % no. % no. % no.  
(%)
Frequency IA 1st 
stage (15-30 mins)
28 71.8 6 15.4 4 10.2 1 (2.6%) 39 100
Frequency IA 
2nd stage (5 mins 
or after every 
contractions)
15 38.5 13 33.3 6 15.4 5 
(12.8%) 
moved 
to EFM 
or 2nd 
stage too 
quickly
39 100
Duration IA (1 
minute)
4 10.5
Duration  and Timing seldom documented
Timing IA (after 
contraction)
9 23
Maternal Pulse 1st 
stage
0 0 17 43.6 21 53.8 1 39 100
Maternal Pulse 
2nd stage
0 0 0 0 35 89.7 4 39 100
documentation  
cEfm  (n=95)
always sometimes never no 
data
total total 
%
no.     % no.    % no.     % no.  %
Events 34 35.7 45 47.3 7 7.3 9 (9.5%) 95 100
Movements 19 20 25 26.3 43 45.2 8 (8.4%) 95 100
Maternal 
Observations
17 17.8 50 52.6 21 22.1 7 (7.4%) 95 100
Opinions 5 5.2 35 36.8 45 47.3 10 
(10.5%)
95 100
DR C BRAVADO 6 6.3 6 6.3 77 81.1 6 (6.3%) 95 100
Baseline Rate 40 42.1 37 38.9 9 9.5 9 (9.5%) 95 100
Variability 24 25.3 47 49.5 16 16.8 8 (8.4%) 95 100
Accelerations 14 14.7 39 41.1 31 32.6 11 
(11.6%)
95 100
Decelerations 20 21.1 44 46.3 15 15.8 16 
(16.8%)
95 100
Categorisation 9 9.5 29 30.5 45 47.4 12 
(12.6%)
95 100
Description 5 5.3 21 22.1 59 62.1 10 
(10.5%)
95 100
Table 4: Documentation standards for IA, CEFM, Interpretation and 
Classification of the 4 main FHR features  
*no data means there was no documentation in the medical record.
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who had an admission CTG had no indications for 
EFM. The current policy states, “There is no evidence 
to support the use of routine admission EFM in 
‘low-risk’ women as this is poorly predictive of fetal 
compromise during labour (DHB policy, 2003 ). 
Over half of the women who had an admission 
CTG went on to have continuous electronic fetal 
monitoring (CEFM). 
In keeping with the NICE (2001) guidelines for the 
use of electronic fetal monitoring, CEFM should 
be offered only to high-risk pregnant women. The 
difficulty has always been adequate identification of 
who is at high risk. A consequence of this difficulty is 
the increasing use of intrapartum admission CTG in 
order to identify which fetuses of low risk women are 
at greater risk and who therefore should have CEFM. 
The admission CTG, or the labour admission test 
(LAT) as it is sometimes referred to in the literature, 
was traditionally a CTG trace of 20-30 mins duration 
carried out on admission to the maternity ward. It is 
a screening test in early labour to detect compromised 
fetuses and to select the women in need of CEFM. 
The main justification for admission CTG is that an 
abnormal trace might indicate a placental deficiency 
and hence identify potential fetal compromise at an 
early stage of labour in order to allow intervention 
(Imprey et al., 2003; Elimian et al., 2003). Gourounti 
and Sandall (2007) in a systematic review concluded 
that although the admission CTG may give an 
indication of fetal well-being at the time of admission 
it cannot predict how the fetus will cope after several 
hours of labour. Thus the admission CTG may 
represent an unnecessary intervention. A systematic 
review (Blix et al., 2005) revealed that women 
randomised to the LAT were more likely to have minor 
obstetric interventions like epidural analgesia, CEFM 
and FBS and concluded that there is no evidence 
supporting that the LAT is beneficial in low risk 
women. Whilst the admission CTG may be reassuring 
for the woman and her family and provide clinicians 
with evidence of monitoring, in the medico-legal sense, 
it is not recommended for low risk women as it is 
known to be associated with increased interventions. 
Women and their intrapartum caregivers should make 
an informed decision about using admission CTG 
based on knowledge of the woman’s pregnancy and the 
initial assessment in labour.
Intermittent Auscultation (IA)
Most recommendations for fetal heart assessment 
using IA during labour are based on protocols used in 
randomized controlled trials (RCTs) that compared 
IA with EFM (Thacker & Stroup, 2000), and these 
guidelines have become custom and common practice 
in many birth settings. 
Intermittent auscultation would normally be 
conducted at predetermined intervals. Those 
predetermined intervals are described in obstetric and 
midwifery texts, polices and guidelines as listening 
to the fetal heart rate every 15-30 minutes in the 
first stage of labour and every five minutes or after 
every contraction in the second stage of labour, and 
should be conducted for at least one full minute 
from the end of the contraction (RCOG, 2001; 
RANZCOG, 2006; RCM, 2005; ACOG, 1995 and 
Lister,2007). The RCOG (2001) guideline accords an 
A grading (at least one RCT as part of the literature 
of overall good quality and consistency addressing the 
specific recommendation) to the recommendations 
regarding frequency, timing and duration of IA, 
whilst RANZCOG (2006) accords a grading of 
C (evidence obtained from expert opinion and/or 
clinical experience of respected authorities - indicates 
an absence of directly applicable studies of good 
quality). The American College of Nurse-Midwives 
(ACNM) (2007) state that guidelines for intermittent 
auscultation based on evidence-based application 
during labour are not available. RANZCOG 
(2006) state that there have been no clinical studies 
comparing different IA frequencies to guide practice.
A recent survey researching NZ midwives’ practice 
of taking maternal and fetal observations in normal 
labour (n=708) revealed that midwives are more likely 
(48%) to listen to the fetal heart every 30 minutes 
(28% every 15 minutes) in the first stage and after 
every contraction (40%) in the second stage (14.3% 
every five minutes) (Muir, 2006). In this current 
audit midwives are reported as ALWAYS meeting 
the criteria for monitoring in first stage (15 – 30 
minutes) 71.8% of the time and every five minutes 
in second stage 38.5% of the time. Recording of the 
maternal pulse is poorly done in both first and second 
stage. During IA, the maternal heart rate should 
be ascertained by feeling the woman’s radial pulse 
concurrent to auscultation the fetal heart rate with 
a Pinard’s or Doppler device. This validates that it is 
the fetal heart rate, not the maternal heart rate that is 
being heard and counted (Goodwin, 2000).
These findings suggest that without robust evidence 
from research to inform frequency, timing and 
duration we only have the guidelines of ‘custom and 
practice’ to inform our practice. There needs to be 
research into the timing, frequency and duration of IA 
for low risk women (Feinstein, 2000). It is important 
for midwives to retain a broad knowledge base and 
clinical competence around the practice of IA and 
uterine activity assessment (Goodwin, 2000) as well as 
understanding the importance of taking the maternal 
pulse concurrent with IA.
Documentation standards related to 
Electronic Fetal Monitoring
Miller (2005) claims that allegations regarding the 
interpretation and management of FHR monitoring 
dominate obstetric litigation (in countries where 
litigation occurs) related to neurologically impaired 
infants. Therefore it is vitally important that the 
information contained on the CTG trace be accurate 
and that CTGs are stored securely for future reference. 
To this end a standardised language and consistent 
approach to interpretation of the findings of EFM 
is vital.  The current policy states – “Any event that 
may effect the fetal heart rate should be noted on the 
EFM trace, signed and the date and time noted. Any 
staff member who is asked to provide an opinion on a 
trace should note their findings on both the trace and 
in the maternal case notes, together with the time and 
their signature” (DHB policy, 2003).
The study demonstrated deficiencies with 
documentation standards related to CTGs. Of 
concern was the high number of times when 
opinions (Never = 47%) were not documented 
in either the medical record or on the CTG (this 
relates to when it had been documented that an 
opinion was sought regarding the CTG). As well, a 
high number of CTGs did not have events (Never/
Sometimes = 64%) that may affect the fetal heart 
recorded on the trace. Events could be insertion or 
top-up of epidural or administration of narcotic, 
vaginal examination, artificial rupture of the 
membranes  or syntocinon titration. The lack of 
documentation around opinions in particular is 
of concern. The guidelines for interpretation and 
classification provide an action plan. If clinicians are 
not documenting their opinions they are unlikely to 
be documenting their action plans either. Because 
CEFM is a screening tool, some form of verification 
of non-reassuring findings is required (Albers, 2001).
New Zealand midwives who provide expert 
midwifery opinion in the medico-legal context 
report being concerned at the large numbers of 
CTG traces that have the incorrect date, time and 
speed (personal communication, 2007). They also 
report that many of the CTG traces are not labelled 
adequately with the woman’s name and unique 
identifying number (NHI number). Consideration 
of the impact of high acuity and staff shortages in 
our maternity units needs to be given to determine 
whether there any correlation with these findings. 
This audit revealed that midwives and doctors are 
not meeting the practice standards for CTGs. There 
were a large number of CTGs with the incorrect date 
and time e.g. CTGs were automatically recording 
04/04/44, 0001 hrs. This occurs when the batteries 
are not replaced. Once the machine is turned off, 
the date and time revert to factory settings. This is 
problematic when a review of the CTG is required at 
a later date. Some practitioners annotate the date and 
time on the CTG, however, the accuracy of this is 
debatable. Some medical records did not contain the 
New Zealand College of Midwives • Journal 40 • April 2009 29
CTG traces at all. From a medico-legal perspective, it 
is vital that all CTG are stored securely in the notes. 
The audit reveals that this occurs 96% of the time. 
Our aim must be for 100% secure storage.
Documentation of findings on CTG
The literature demonstrates a lack of consistency 
and agreement in interpretation and classification of 
the findings of CTGs. Experts generally agree about 
the definitions of the normal FHR tracing and, at 
the other end of the spectrum, the FHR patterns 
which are predictive of current or impending fetal 
asphyxia. However most of the controversy exists in 
the interpretation of FHR patterns that lie between 
these two extremes and their presumed condition 
and clinical management (Parer, 1997). Parer and 
King (2000) suggested that an unwritten and 
undemonstrated aspect of FHR monitoring was the 
issue of reliable and reproducible interpretations of 
FHR patterns by health care professionals. Studies 
conducted into reliability and reproducibility show 
that although there is general agreement on patterns, 
inter-observer and intra-observer consistency is poor. 
The adoption of a common language for FHR 
pattern interpretation and documentation 
that is agreed on and routinely used enhances 
communication between practitioners (Simpson 
& Knox, 2000). Simpson and Knox go on to say, 
“the chances of miscommunication between care 
providers, especially during telephone conversations 
about fetal status, are decreased when everyone is 
speaking the same language about EFM. Thus timely 
intervention during non-reassuring FHR patterns is 
more likely” (p.43).
Guidelines for the interpretation of CTGs are 
published by, amongst others, the RANZCOG 
(2006) and RCOG/NICE (2001).  These need to 
be interpreted with due consideration to the clinical 
context. Practitioners who have trained through 
the Advanced Life Support in Obstetrics [ALSO] 
(AAFP, 2001) course may wish to utilize the “DR C 
BRAVADO” mnemonic (DR – describe risk, C – 
contractions, BRA – baseline rate, A – accelerations, VA 
– variability, D – decelerations, O – overall assessment) 
to systematically review CTGs (DHB policy, 2003). 
The study revealed that clinicians in this DHB only 
used DR C BRAVADO as a tool for interpreting 
FHR features 20% of the time. However, it is not 
known how many midwives and doctors have 
completed the ALSO course. The alternative 
interpretation framework to use recommends an 
assessment of all four FH features (baseline rate, 
variability, accelerations and decelerations) and the 
use of standardised language (reassuring, non-
reassuring and abnormal) to ensure consistency of 
understanding. All of these four features must be 
assessed alongside the presence and quality of uterine 
activity. The significance of EFM findings is useless in 
the absence of concurrent uterine activity monitoring.
The most illuminating finding of the study was the 
lack of overall description of CTGs. In the guideline, 
the descriptions (Normal, Suspicious, Pathological, 
Acute Fetal Compromise, Uterine Tachysystole and 
Hyper-stimulation) all have associated action plans to 
guide practitioners.  
rEcommEndations
Midwives and doctors should receive annual joint 
education on fetal surveillance and CTG interpretation 
as a core competency standard for all staff involved in 
intrapartum care. Formal learning is complimented 
by annual completion of the computerised learning 
packages such as  K2 fetal monitoring  
(http://training.k2ms.com) and the RANZCOG 
online fetal surveillance education programme  
(http://www.ranzcog.edu.au/fse_program/index.
shtml) and weekly review of CTG strip presentations 
in Delivery Suite. Midwives would benefit from 
education in the techniques of intermittent 
auscultation and uterine palpation to re-ground them 
in normal physiology and help to improve confidence 
in this technique for well women and babies. A 
re-audit after the introduction of the standardised 
template for reporting CTG and a multidisciplinary 
education programme is recommended.
conclusion 
The policy for Intrapartum EFM employed at this 
DHB is a based around the RCOG/NICE 2001 
guideline which has been robustly assessed against the 
evidence. This audit demonstrates that practitioners 
were not using the guidelines adequately or effectively 
and improvements could be made. 
Globally it is known that inter-observer and 
intra-observer consistency is poor when it comes 
to interpretation of the findings of CTGs. The 
implications of this lack of consistent use of 
standardised language and interpretation of the 
findings of EFM is that the effectiveness of FHR 
monitoring as a reliable screening tool is weakened 
ctg date:             ctg time: maternal Pulse:
determine risk 
ctg indication 
 low              medium high
Contractions: ……  in  10 mins   Mild  / Medium / Strong
Baseline Rate: Reassuring  
• 110 - 160
Non-Reassuring 
• 100 – 109 or 160 -180
Abnormal 
• < 100 or > 180
Variability: Reassuring 
• > 5 bpm
Non-Reassuring
• < 5 bpm > 40 mins 
and < 90 mins
Abnormal 
• < 5 bpm > 90 mins
Accelerations: 
_ 15 bpm 
lasting > 15 
secs
Reassuring 
• Present
Non-Reassuring 
• Absent
Abnormal 
• Absent
Decelerations: Reassuring 
• No decelerations
Non-Reassuring
• Early, Variable, Single 
prolonged < 3 mins
Abnormal
• Atypical variable, Late, 
Single prolonged > 3 
mins
Overall 
Assessment:
Normal    
• All 4 features reassuring
Suspicious
• 1 non-reassuring 
feature
• Consultation Required  
Pathological
• 2 or more features non-
reassuring or abnormal
• Urgent Consultation
Comments:
 
Plan:
 
 
 
Continue CTG                  Review in …
Signature: Print Name:
Table 5: A standardised template for reporting CTGs
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(Parer & King, 2000; Simpson & Knox, 2000).  
This DHB’s policy used a standardised language and 
interpretation framework to assist and guide action, 
but compliance was not adequate. The authors believe 
that the introduction of a standardised template for 
CTG assessment, interpretation and action planning 
(based on the policy in use at the DHB) (Table 5) will 
contribute to improved practice and outcomes. The 
template is in the form of a sticky label which is filled 
in and placed in the woman’s medical record every 
time the CTG is assessed. It is important that midwives 
and doctors are educated to use these intrapartum fetal 
monitoring guidelines and the reporting template. 
Consistency in interpretation comes from regular 
education sessions/updates. Greater consistency comes 
from having a shared understanding.
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